Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bill-Axelson

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Lakartidningen|June 13, 2003
[Radical prostatectomy reduces the risk of death in prostatic cancer. The effect on total mortality can not be established yet as shown in a randomized controlled trial]Anna Bill-Axelson, Lars Holmberg, Jan-Erik Johansson, et al.
Plos One|July 28, 2021
A drug comorbidity index to predict mortality in men with castration resistant prostate cancerGiuseppe Fallara, Rolf Gedeborg, Anna Bill-Axelson, et al.
Lakartidningen|May 29, 2014
[Radical prostatectomy evaluated. 18 year follow up of Swedish randomized multicenter study]Hans-Olov Adami, Anna Bill-Axelson, Lars Holmberg, et al.
Scandinavian Journal of Urology and Nephrology|February 21, 2009
Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trialAnna Bill-Axelson, Anna Christensson, Marianne Carlsson, et al.
Scandinavian Journal of Urology|December 19, 2024
Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide studyJovana Maljkovic, Anna Bill-Axelson, Hampus Hållberg, et al.
BMJ Open|December 26, 2019
Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based studyOskar Bergengren, Hans Garmo, Ola Bratt, et al.
BMJ (Clinical Research Ed.)|June 20, 2013
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control studyDavid Robinson, Hans Garmo, Anna Bill-Axelson, et al.
European Urology Oncology|May 18, 2019
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based StudyOskar Bergengren, Hans Garmo, Ola Bratt, et al.
JAMA Network Open|May 17, 2021
Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year CohortOskar Bergengren, Marcus Westerberg, Lars Holmberg, et al.
JAMA Network Open|September 14, 2022
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in SwedenEugenio Ventimiglia, Anna Bill-Axelson, Ola Bratt, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Lakartidningen|June 13, 2003
[Radical prostatectomy reduces the risk of death in prostatic cancer. The effect on total mortality can not be established yet as shown in a randomized controlled trial]Anna Bill-Axelson, Lars Holmberg, Jan-Erik Johansson, et al.
Plos One|July 28, 2021
A drug comorbidity index to predict mortality in men with castration resistant prostate cancerGiuseppe Fallara, Rolf Gedeborg, Anna Bill-Axelson, et al.
Lakartidningen|May 29, 2014
[Radical prostatectomy evaluated. 18 year follow up of Swedish randomized multicenter study]Hans-Olov Adami, Anna Bill-Axelson, Lars Holmberg, et al.
Scandinavian Journal of Urology and Nephrology|February 21, 2009
Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trialAnna Bill-Axelson, Anna Christensson, Marianne Carlsson, et al.
Scandinavian Journal of Urology|December 19, 2024
Time trends for the use of active surveillance and deferred treatment for localised prostate cancer in Sweden: a nationwide studyJovana Maljkovic, Anna Bill-Axelson, Hampus Hållberg, et al.
BMJ Open|December 26, 2019
Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based studyOskar Bergengren, Hans Garmo, Ola Bratt, et al.
BMJ (Clinical Research Ed.)|June 20, 2013
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control studyDavid Robinson, Hans Garmo, Anna Bill-Axelson, et al.
European Urology Oncology|May 18, 2019
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based StudyOskar Bergengren, Hans Garmo, Ola Bratt, et al.
JAMA Network Open|May 17, 2021
Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year CohortOskar Bergengren, Marcus Westerberg, Lars Holmberg, et al.
JAMA Network Open|September 14, 2022
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in SwedenEugenio Ventimiglia, Anna Bill-Axelson, Ola Bratt, et al.
Pageof 9